[ad_1] The title of BB Biotech (WKN: A0NFN3 / ISIN: CH0038389992) is an excellent alternative to special funds in the biotechnology sector. As an investment company, BB Biotech has the advantages of …
Read More »BB Biotech loses 70 million francs in six months | 07/12/18
[ad_1] Schaffhausen (awp) – BB Biotech anticipates a loss of about CHF 70 million in the first half of fiscal 2018. During the same period of the previous year, the company's 39; …
Read More »Biotech – Idorsia successfully places new shares and convertible bonds | new
[ad_1] On the stock market, Idorsia shares are passed to the news after the news. Specifically, the major shareholders Jean-Paul and Martine Clozel 28.4 percent of the shares and 28.4 percent of …
Read More »